Free Trial
LON:SEED

Seed Innovations Interim Earnings Results & Report

GBX 2.27 +0.07 (+3.18%)
As of 04:48 AM Eastern

Seed Innovations reported Interim earnings on December 3, 2024. The company reported EPS of -GBX 0.39.

Earnings Announcement Details

Quarter
Interim
Report Date
Time
Before Market Opens

Seed Innovations EPS Results

Actual EPS
-GBX 0.39
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Seed Innovations Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Seed Innovations Interim Earnings FAQ

Seed Innovations (LON:SEED) reported earnings of -GBX 0.39 per share for Interim. The report was announced on Tuesday, December 3, 2024.

Seed Innovations Earnings Headlines

The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
See More Seed Innovations Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seed Innovations? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seed Innovations and other key companies, straight to your email.

About Seed Innovations

Seed Innovations (LON:SEED) Ltd is an AIM-quoted investment company focused on leveraging deep sector expertise and strategic insight to identify and invest in high-potential opportunities across the rapidly evolving humanoid robotics and artificial intelligence (AI) landscape. By targeting transformative technologies and future-focused businesses, SEED aims to deliver long-term value creation and sustainable returns for shareholders. Alongside this core strategy, the Company continues to manage a legacy portfolio in wellness and life sciences, with a medium-term objective of full value realisation.

View Seed Innovations Profile